key: cord-0999527-chmrhcl3
authors: Tablizo, Francis A.; Saloma, Cynthia P.; Castro, Marc Jerrone R.; Kim, Kenneth M.; Yangzon, Maria Sofia L.; Lapid, Carlo M.; Maralit, Benedict A.; Ayes, Marc Edsel C.; Yap, Jan Michael C.; Llames, Jo-Hannah S.; Araiza, Shiela Mae M.; Punayan, Kris P.; Asin, Irish Coleen A.; Tambaoan, Candice Francheska B.; Chong, Asia Louisa U.; Padilla, Karol Sophia Agape R.; Cruz, Rianna Patricia S.; Morado, El King D.; Dizon, Joshua Gregor A.; Cutiongco-de la Paz, Eva Maria; de Guzman, Alethea R.; Hao, Razel Nikka M.; Zamora, Arianne A.; Pacial, Devon Ray; Magalang, Juan Antonio R.; Alejandria, Marissa; Carlos, Celia; Ong-Lim, Anna; Salvaña, Edsel Maurice; Wong, John Q.; Montoya, Jaime C.; Singh-Vergeire, Maria Rosario
title: Detection and Genome Sequencing of SARS-CoV-2 Variants Belonging to the B.1.1.7 Lineage in the Philippines
date: 2021-05-06
journal: Microbiol Resour Announc
DOI: 10.1128/mra.00219-21
sha: ebc2f4161473b775e3cc3207077cc6c10efc8845
doc_id: 999527
cord_uid: chmrhcl3

We report the sequencing and detection of 36 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples containing lineage-defining mutations specific to viruses belonging to the B.1.1.7 lineage in the Philippines.

C oronavirus disease 2019 (COVID-19) is an infectious disease that has gained pandemic status from the World Health Organization, with millions of cases and deaths recorded worldwide. This global health crisis is caused by the virus referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the genus Betacoronavirus (Coronaviridae), together with the causative agents of the first SARS outbreak in 2003 and the Middle East respiratory syndrome (MERS) in 2012.

In this study, we present the genome sequences of 36 cases of COVID-19 in the Philippines caused by viruses belonging to SARS-CoV-2 lineage B.1.1.7, also referred to as 20I/501Y.V1 or the variant of concern (VOC) 202012/01. This particular SARS-CoV-2 variant was initially identified in the United Kingdom and has been reported to cause a surge of COVID-19 infections in that country (1) . Initial studies also suggest that the B.1.1.7 viruses appear to have a replicative advantage (2) and are more transmissible (3) . The protocols used in this study were reviewed and approved by the Single Joint Research Ethics Board of the Department of Health, with approval code SJREB-2021-11, as part of a larger research program entitled "A retrospective study on the national genomic surveillance of COVID-19 transmission in the Philippines by SARS-CoV-2 genome sequencing and bioinformatics analysis."

In order to detect the entry of B.1.1.7 infection into the Philippines, nasopharyngeal swabs were collected between 10 December 2020 and 31 January 2021 from COVID-19 cases detected in returning overseas Filipinos, as well as from local case clusters, mainly from the Cordillera Administrative Region of the country, among others. Only reverse transcriptase PCR (RT-PCR)-positive cases with a cycle threshold (C T ) value below 30 in any gene target were considered for the subsequent sequence analysis. The collected swab samples were then subjected to RNA extraction using the QIAamp viral RNA minikit, the product of which was used as the template for the ampliconbased Illumina COVIDSeq test sequencing workflow.

The resulting sequence reads were mapped to the reference SARS-CoV-2 genome (NCBI accession number NC_045512.2) using minimap2 version 2.17-r941 (4), with the "-x sr" parameter for accurate genomic short-read alignment. Primer clipping and quality trimming, intrahost variant calling, removal of reads associated with mismatched primer indices, and consensus sequence assembly were then performed following the suggested workflow of iVar version 1.2.2 (5), using default parameters. The consensus variants were identified by comparing the resulting assemblies with the reference sequence using MUMmer (6) , as implemented in RATT software (7) . Lastly, SARS-CoV-2 lineage classifications (8) were assigned using PANGOLIN version 2.3.2 (https://github .com/cov-lineages/pangolin). A total of 36 Philippine SARS-CoV-2 samples were classified under the B.1.1.7 lineage. Table 1 shows the primary consensus assembly metrics for these samples. The average depth of coverage across all the sequences is 1,183Â, with 26 of the samples carrying all 17 hallmark mutations of the B.1.1.7 lineage as listed in the PANGO lineages report for the B.1.1.7 variant of concern (https://cov-lineages.org/global_report_B.1.1.7 .html).

The detection of B.1.1.7 from returning overseas Filipino workers and in the community highlights the need for genomic surveillance at the country's ports of entry and in the general population to monitor the importation and local transmission of emerging variants of concern that may impact the public health response to the SARS-CoV-2 pandemic in the Philippines. Data availability. The consensus sequence assemblies reported in this study have been deposited in the NCBI GenBank database, and their corresponding read alignments (BAM format) are in the NCBI Sequence Read Archive (SRA) database under BioProject accession number PRJNA708134. The accession numbers for the GenBank and SRA submissions are provided in Table 1 .

New variant of SARS-CoV-2 in UK causes surge of COVID-19

SARS-CoV-2 variant of concern 202012/01 has about twofold replicative advantage and acquires concerning mutations

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom

minimap2: pairwise alignment for nucleotide sequences

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

Versatile and open software for comparing large genomes

RATT: rapid annotation transfer tool

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

This project was supported by a Genomics Biosurveillance grant from the Philippine Department of Health and a Department of Science and Technology-Philippine Council for Health Research and Development grant to B.A.M. and the University of the Philippines. We also thank the Philippine Genomic Biosurveillance Network contributing institutions.